Mainz Biomed has announced a partnership with Quest Diagnostics to support the commercialisation of its NextGen colorectal ...

A non-invasive, easy-to-use test, like the Cologuard test, is a simple and effective way to screen for colorectal cancer. In ...

(RTTNews) - Mainz Biomed N.V. (MYNZ), Thursday announced a collaboration with Quest Diagnostics Inc. (DGX) to commercialize the former's NextGen screening test for colorectal cancer, called ColoAlert ...

Quest to Support Mainz Biomed’s ReconAAsense FDA Study and Has Option to Commercialize Test Kit Assuming FDA ApprovalBERKELEY ...

Mainz Biomed Forms Agreement with Quest Diagnostics to Provide Clinical Trials Laboratory Services for Colorectal Cancer Screening Test Quest to Support Mainz Biomed’s ReconAAsense FDA Study and Has ...

Intervention participants were more likely to complete screening and to have detection of advanced colorectal neoplasia.

A first-of-its-kind urine test for the early detection of lung cancer has been developed by University of Cambridge scientists. It detects ‘zombie’ cells that could indicate the first signs of the ...

A healthcare firm, Codix Group, has received World Health Organisation approval to package a prequalified Rapid Diagnostic test kit locally. In a statement, Codix Group, a subsidiary of Colexa ...

With colon cancer rates rising, advocates hope a newly approved blood test screening can help more people catch it early. “If we find it early, we have a lot more options in treating it,” said Dr.

can be used alongside screening to lower cervical cancer rates later in a person’s life. The task force still recommends women ages 21 to 29 receive Pap test every three years, because they may ...

While bowel cancer – or colorectal cancer – has traditionally been more common in people over the age of 50, cases in the ...

ENGLAND has one of the world’s fastest rising rates of bowel cancer in under-50s, a major study has warned. The American ...